RECALL: Ventolin Diskus inhalers

Health Canada and GlaxoSmithKline Inc. are voluntarily recalling Ventolin Diskus inhalers for not delivering an accurate dose of medication.

PHOTO: GLAXOSMITHKLINE INC.

Health Canada and GlaxoSmithKline Inc. are voluntarily recalling one lot of Ventolin Diskus inhalers after discovering that they may not deliver the intended dose of medication and could result in a potentially life-threatening asthma attack.

Ventolin Diskus is a drug prescribed to adults and children four years or older to relieve and prevent bronchospasm (a sudden worsening of shortness of breath and wheezing) from asthma, chronic bronchitis and other chronic lung disorders. The inhalers are also used to prevent exercise-induced bronchospasm.

If individuals do not receive the correct therapeutic dose as expected, their symptoms (coughing, wheezing, breathlessness or tight chest) may worsen over time, potentially having serious health consequences, including a potentially life-threatening asthma attack.

GlaxoSmithKline Inc. issued the recall after identifying a manufacturing issue with lot 786G, specifically, that may have resulted in a small number of devices not delivering the full number of doses.

What should you do?
If you have an inhaler from lot 786G, return it to the pharmacy for a replacement. For more information about the recall, contact GlaxoSmithKline Inc. (GSK) via Stericycle by calling, toll-free, 1-855-215-5956. If you are experiencing continued symptoms after using their Ventolin Diskus, you should seek medical attention as soon as possible.

Read Health Canada’s full recall notice here.

Read more:
RECALL: Paldo brand seaweed snacks
RECALL: Rock Solo Karaoke Microphone & Speaker

No Comments